About eight million people live with Type 1 diabetes (T1D) worldwide, a chronic autoimmune condition in which the body attacks and destroys its own insulin-producing β-cells (pronounced “beta”) in the pancreas, leading to a lack of insulin and inability to regulate blood sugar.
Madrigal builds on liver disease awareness campaigns as it awaits FDA decision on NASH drug resmetirom
Madrigal Pharmaceuticals wants people with fatty liver disease to be the number one fan of their livers. Its new “patient service announcement,” shown first on
November 11, 2023